Loading...
Symbols:
Loading...
Symbols:
Cell Therapeutics Inc. (CTIC)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Cell Therapeutics Inc. (CTIC)
21 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CTIC
- Alan Brochstein(8)
- Centient Biotech Investor(7)
- 10Q Detective(2)
- George Gutowski(1)
- Fat Pitch Financials(1)
Most popular authors
(tracked in watchlists)
- Alan Brochstein(119)
- 10Q Detective(14)
- Fat Pitch Financials(11)
- George Gutowski(4)
- Centient Biotech Investor(3)
Most commented on authors
- Cancer Stocks Finish a Tough Quarter
- Cell Therapeutics Starts Phase III Lung Cancer Trial
- 66 Biggest Losers From Today's Selloff
- Cancer Stocks: Lagging Again
- Cancer Stocks: Tracking the Market
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cell Therapeutics: Mixed Shelf Registration News Sinks Stock
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Biotech Day In Review: MedImmune Puts Itself Up For Sale
- Biotech Stocks: InterMune Retrenches
-
Biotech Day In Review: InterMune Scaling Back Operations, MGI's Positive Trial
on Mar 21, 2007
- Biotech Day in Review: Glaxo Gets Approval for Tykerb
- Biotech Day in Review: New River/Shire Win Approval for ADHD Drug
- Biotech Day In Review: Merger Monday
- Biotech Day in Review: Big Pharma Merger in Japan
- Biotech Stocks Day-in-Review: Genentech Beats Estimates
- Cell Therapeutics: Cytotoxic to Shareholders?
- Weekend Follies: Press Releases While Nobody’s Looking
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »